P85.03 PD-L1 Expression and Efficacy of Immunotherapy in Japanese Patients with NSCLC Harboring MET Exon 14 Skipping Mutation.
暂无分享,去创建一个
G. Yamamoto | K. Akagi | Y. Yamane | H. Sakai | F. Kurimoto | Y. Kato | H. Mizutani | Y. Watanabe
暂无分享,去创建一个
G. Yamamoto | K. Akagi | Y. Yamane | H. Sakai | F. Kurimoto | Y. Kato | H. Mizutani | Y. Watanabe